✦ LIBER ✦

9404 A Phase II study of cediranib in patients with metastatic gastrointestinal stromal tumours (GIST) and metastatic soft tissue sarcoma (STS) (including alveolar soft part sarcoma [ASPS])

✍ Scribed by Gardner, K.; Judson, I.; Leahy, M.; Barquin, E.; Marotti, M.; Collins, B.; Young, H.; Scurr, M.

Book ID: 122042944
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 50 KB
Volume: 7
Category: Article
ISSN: 1359-6349
DOI: 10.1016/S1359-6349(09)71992-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A two-arm phase II study of temozolomide

A two-arm phase II study of temozolomide in patients with advanced gastrointestinal stromal tumors and other soft tissue sarcomas

✍ Jonathan C. Trent; Jennifer Beach; Michael A. Burgess; Nicholas Papadopolous; Le 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 141 KB 👁 2 views

## Abstract ## BACKGROUND The authors conducted a two‐arm Phase II study of temozolomide to determine its efficacy and toxicity in patients with soft tissue sarcomas (STSs) who had received, had refused, or were not eligible for standard chemotherapy with doxorubicin and ifosfamide (Arm 1) and in

Randomized Phase II Study of Gemcitabine

Randomized Phase II Study of Gemcitabine and Docetaxel Compared With Gemcitabine Alone in Patients With Metastatic Soft Tissue Sarcomas: Results of Sarcoma Alliance for Research Through Collaboration Study 002

✍ Maki, R. G.; Wathen, J. K.; Patel, S. R.; Priebat, D. A.; Okuno, S. H.; Samuels, 📂 Article 📅 2007 🏛 American Society of Clinical Oncology 🌐 English ⚖ 163 KB

Use of c-KIT/PDGFRA mutational analysis

Use of c-KIT/PDGFRA mutational analysis to predict the clinical response to imatinib in patients with advanced gastrointestinal stromal tumours entered on phase I and II studies of the EORTC Soft Tissue and Bone Sarcoma Group

✍ M. Debiec-Rychter; H. Dumez; I. Judson; B. Wasag; J. Verweij; M. Brown; S. Dimit 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 309 KB